Browsing by Author "Abubeker, Ibrahim Y."
Now showing items 1-3 of 3
-
Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis
Elshafei, Mohamed Nabil; El-Bardissy, Ahmed; Khalil, Ahmed; Danjuma, Mohammed; Mubasher, Mahmood; Abubeker, Ibrahim Y.; Mohamed, Mouhand F.H.... more authors ... less authors ( Wiley-Blackwell , 2021 , Article)Background: Colchicine was recently repurposed for the management of coronavirus disease 2019 (COVID-19). This rapid review and meta-analysis aimed to assess colchicine's impact on mortality outcomes in COVID-19 patients. ... -
An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools
Danjuma, Mohammed Ibn Mas ud; Shokri, Shaikha Al; Abubeker, Ibrahim Y.; Malik, Ashraf El; Abdallah, Ibtihal Mahmoud Hassan; Shafei, Mohamed Nabil El; Fatima, Haajra; Mahmoud, Mohamed; Hussain, Tanweer; Maghoub, Yahya; Sajid, Jamal; Zouki, Abdel Naser El... more authors ... less authors ( Wolters Kluwer Health , 2020 , Article)An adverse drug reactions avoidability tool called the Liverpool ADR avoidability assessment tool (LAAT) was recently developed (for research purposes), and subsequently validated with mixed interrater reliability (IRR). ... -
An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome
Danjuma, Mohammed Ibn Mas’ud; Naseralallah, Lina Mohammad Ahmad; AbouJabal, Bodoor; Mohamed, Mouhand Faisal; Abubeker, Ibrahim Y.; Jabbar, Layla Abdul; Elzouki, Abdelnaser... more authors ... less authors ( Springer Nature , 2021 , Article)Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rising morbidity amongst hospitalized patients. Whilst clinical protocols for the management of individual DRESS cases have been well established, ...